Take Solutions

Chennai, India Founded: 2000 • Age: 26 yrs Listed
Life sciences and supply chain management services are provided.
Request Access
Report Incorrect Data
Page last updated

About Take Solutions

Take Solutions is a publicly listed company based in Chennai (India) founded in 2000. Life sciences and supply chain management services are provided. The company has 376 employees. Take Solutions has completed 1 acquisition, including WCI Consulting. Its chief executive, as recorded, is Ram Yeleswarapu. Its website takesolutions.com draws about 18 thousand monthly visits. Its Indian entity Take Solutions Limited reported revenue of ₹67.47 Cr. Take Solutions offers products and services including Digital Healthcare Services and Supply Chain Management. Its focus areas include Biopharma Outsourcing and Logistics & Supply Chain.

Company details

Take Solutions was founded in 2000 and is based in Chennai, India. Operations are centered on the life sciences sector, where clinical data management and regulatory solutions are delivered. In supply chain management, logistics optimization and inventory systems are offered to various industries. The company serves clients across multiple geographies, with leadership provided by CEO and President Ram Yeleswarapu.

  • Headquarters Chennai, India
  • Employees 376
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website takesolutions.com
  • Social LinkedIn X
  • Legal Name Take Solutions Limited
Operational Areas
Healthcare → Biopharma Outsourcing & Drug Delivery
Key Metrics
  • Market Cap
    ₹191 Cr

    TAKE · NSE

  • Share Price
    ₹12.92

    -1.90% today

  • Revenue
    ₹54.19 Cr

    FY 2025-26

  • EBITDA
    −₹1.91 Cr

    Margin -3.5%

  • Net Profit
    ₹4.26 Cr

    FY 2025-26 · -88.7% YoY

  • P/E (TTM)
    33.0x

    P/B 6.3x

  • ROE
    0.6%

    ROCE 0.7%

  • Latest Funding Round
    $40M (USD), Post-IPO

    Feb 2018

  • Employee Count
    376
  • Investments & Acquisitions
    WCI Consulting

Products & Services of Take Solutions

Take Solutions offers a comprehensive portfolio of products and services, including Digital Healthcare Services and Supply Chain Management.

Digital Healthcare Services
Healthcare Technology

Services for clinical development in life sciences sectors.

Supply Chain Management
Logistics

Point services for efficient supply chain operations globally.

Funding Insights of Take Solutions

  • Total Rounds 1
  • Last Round Post-IPO — $40M
  • First Round $40M

    (Feb 2018)

All 1 funding rounds of Take Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2018$40MPost-IPO––
–

Board of directors of Take Solutions Limited (Take Solutions)

Take Solutions Limited is the primary company behind Take Solutions. The board of Take Solutions Limited currently have 6 directors; the longest-serving is Vedamirtham Venkatesan, appointed in 2025. 34 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vedamirtham Venkatesan
DIN 00194600
Director01 May 20251 yr 6 moTake Solutions Limited
Cecily Dheepa
DIN 07900799
Director01 May 20251 yr 6 moTake Solutions Limited
Pushpa Joshi
DIN 06838093
Director24 May 20251 yr 5 moTake Solutions Limited
Peeyush Sethia
DIN 09850692
Director24 May 20251 yr 5 moTake Solutions Limited
Kanwar Nitin Singh
DIN 10204543
Director24 May 20251 yr 5 moTake Solutions Limited
Parmeshvar Namdev Dhangare
DIN 11410125
Additional Director12 Dec 202510 moTake Solutions Limited

People of Take Solutions

1 people are tracked at Take Solutions (1 in leadership); the tracked headcount is 376.

NameRoleGroup
Ram Yeleswarapu
CEO & PresidentLeadership
Premium access

Complete people profiles for Take Solutions

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Take Solutions

Take Solutions is a publicly listed company on the NSE with ticker symbol TAKE in India, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date27 Aug 2007
  • Listed onBSE: 532890 · NSE: TAKE
  • Listed entityTAKE Solutions Limited
  • Exchange sectorTechnology services
  • ISININE142I01023
  • Share price₹11.46 (-4.98% on the day) · 2026-10-14
  • Market capitalisation₹179 Cr
  • Price to earnings13.1
  • EPS (diluted, trailing year)₹0.87
  • Volume (last session)1,043,472

Financials of Take Solutions

Exchange-reported figures of Take Solutions Limited, the listed company behind Take Solutions (NSE: TAKE).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹54.19 Cr
EBITDA
−₹1.91 Cr
+74.5% YoY
Profit After Tax
₹4.26 Cr
-88.6% YoY
Net Worth
₹31.00 Cr
+51.1% YoY
Total Assets
₹31.00 Cr
+51.0% YoY
Total Debt
Nil

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue54.190.003.601896557742,213
Revenue growth--100.0%-98.1%-71.1%-15.4%-65.0%-
EBITDA(1.91)(7.48)(113)(82.83)(686)(298)169
EBITDA margin-3.5%--3152.2%-43.8%-104.7%-38.5%+7.6%
Profit before tax11.0137.47(116)(98.67)(779)(437)(12.91)
Net profit4.2637.52(80.06)(90.48)(782)(235)(12.38)
Net profit margin+7.9%--2223.9%-47.9%-119.4%-30.3%-0.6%
EPS (₹)0.732.56(8.18)(6.86)(53.50)(30.91)(0.85)
Balance sheet
Total assets31.0020.5329.451562601,6732,185
Net worth31.0020.52(8.88)1091811,1251,575
Total debt0.000.0037.0946.3758.51514553
Cash & bank0.283.430.9511.1729.5039.2945.49
Net working capital18.537.60(23.36)21.76123716913
Cash flow
Cash from operations(4.13)(16.37)9.3220.0229.62135211
Cash from investing1.7422.13(7.46)(2.57)14.92(57.45)(233)
Cash from financing(0.72)(3.24)(11.74)(35.72)(54.51)(83.95)20.54
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue30.3754.190.000.000.000.000.000.00
Other income1.335.181.466.920.041.7051.310.00
EBITDA(0.27)(0.82)(0.35)(0.29)(0.77)(6.32)(2.89)(1.12)
EBITDA margin-0.9%-1.5%------
Depreciation0.000.000.000.000.000.010.010.01
Interest0.000.000.000.170.180.240.730.50
Profit before tax1.064.361.116.46(0.91)(4.87)47.68(1.63)
Tax0.000.000.000.160.000.000.00(0.06)
Net profit1.064.361.116.30(0.91)(4.87)47.68(1.57)
EPS (₹)0.070.290.070.43(0.06)(0.33)3.26(0.11)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue0.000.905.4256.2318.0010.722.47
Revenue growth-100.0%-83.4%-90.4%+212.4%+67.9%+334.0%-
EBITDA(3.44)(81.92)(203)(2.58)(491)(6.87)(16.90)
EBITDA margin--9102.2%-3739.1%-4.6%-2725.3%-64.1%-684.2%
Profit before tax2.89(69.73)(203)4.70(475)6.526.95
Net profit2.72(69.68)(146)8.66(472)(6.02)7.74
Net profit margin--7742.2%-2702.8%+15.4%-2622.6%-56.2%+313.4%
EPS (₹)0.18(4.71)(14.01)0.29(32.26)0.530.52
Balance sheet
Total assets28.4925.7795.70305302776773
Net worth28.4825.7795.41303298775766
Total debt0.000.000.001.822.390.003.85
Cash & bank0.263.220.606.532.7811.501.04
Net working capital19.4816.56(16.67)45.2494.70242232
Cash flow
Cash from operations(0.62)(19.51)(4.48)26.8932.58(2.66)(14.91)
Cash from investing(1.99)22.21(1.02)(22.37)(40.19)13.4221.79
Cash from financing(0.29)(0.04)(0.23)(0.84)(1.11)(0.25)(8.26)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11.970.000.00(0.04)0.000.000.000.00
Revenue growth (YoY)-----100.0%---
Other income1.335.181.460.010.0110.872.91(0.35)
Total expenses12.330.790.350.282.025.881.7427.10
EBITDA(0.36)(0.79)(0.35)(0.32)(2.02)(5.88)(1.74)(27.10)
EBITDA margin-3.0%--+800.0%----
Depreciation0.000.000.000.000.000.010.010.01
Interest0.000.000.000.150.150.200.220.16
Profit before tax0.974.391.11(0.46)(2.16)4.780.94(27.62)
Tax0.000.000.000.160.000.000.00(0.06)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 10 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue30.3754.190.000.000.000.000.000.00
Other income1.335.181.466.920.041.7051.310.00
EBITDA(0.27)(0.82)(0.35)(0.29)(0.77)(6.32)(2.89)(1.12)
EBITDA margin-0.9%-1.5%------
Depreciation0.000.000.000.000.000.010.010.01
Interest0.000.000.000.170.180.240.730.50
Profit before tax1.064.361.116.46(0.91)(4.87)47.68(1.63)
Tax0.000.000.000.160.000.000.00(0.06)
Net profit1.064.361.116.30(0.91)(4.87)47.68(1.57)
EPS (₹)0.070.290.070.43(0.06)(0.33)3.26(0.11)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue54.190.003.601896557742,213
Revenue growth--100.0%-98.1%-71.1%-15.4%-65.0%-
Other income13.2846.950.868.4516.5714.2726.39
Total expenses56.107.481172721,3411,0722,044
Employee cost0.421.102.0647.91309474719
EBITDA(1.91)(7.48)(113)(82.83)(686)(298)169
EBITDA margin-3.5%--3152.2%-43.8%-104.7%-38.5%+7.6%
Depreciation0.010.040.7216.8479.81115167
Interest0.351.962.277.4529.3437.3141.27
Profit before tax11.0137.47(116)(98.67)(779)(437)(12.91)
Tax0.160.004.011.683.6213.56(1.97)
Net profit4.2637.52(80.06)(90.48)(782)(235)(12.38)
Net profit margin+7.9%--2223.9%-47.9%-119.4%-30.3%-0.6%
EPS (₹)0.732.56(8.18)(6.86)(53.50)(30.91)(0.85)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital14.7914.6214.6214.6214.6214.6214.62
Reserves & surplus16.215.90(23.50)93.981661,1101,561
Shareholders' funds (net worth)31.0020.52(8.88)1091811,1251,575
Minority interest0.000.000.000.00(0.42)(0.39)10.04
Secured loans0.000.0027.9633.2658.51514553
Unsecured loans0.000.009.1313.110.000.000.00
Total debt0.000.0037.0946.3758.51514553
Total liabilities31.0020.5329.451562601,6732,185
Assets
Gross block0.030.0361.201128921,6361,786
Net block0.000.0130.2573.191019341,234
Capital work in progress0.000.000.0010.723.390.210.83
Investments0.000.000.000.000.007.4417.50
Inventories0.000.000.800.780.650.613.42
Sundry debtors0.220.007.0530.0481.51434701
Cash & bank balances0.283.430.9511.1729.5039.2945.49
Loans & advances23.2720.1226.4948.21975387443
Total current assets23.7723.5535.2990.201,0868611,193
Total current liabilities5.2415.9558.6568.44963145280
Net working capital18.537.60(23.36)21.76123716913
Total assets31.0020.5329.451562601,6732,185
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash3.370.8510.7229.0038.9745.1346.77
Net cash from operating activities(4.13)(16.37)9.3220.0229.62135211
Net cash from investing activities1.7422.13(7.46)(2.57)14.92(57.45)(233)
Net cash from financing activities(0.72)(3.24)(11.74)(35.72)(54.51)(83.95)20.54
Net change in cash(3.11)2.52(9.88)(18.27)(9.98)(6.16)(1.63)
Closing cash0.283.430.9511.1729.5039.2945.49
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth--100.0%-98.1%-71.1%-15.4%-65.0%-
EBITDA growth+74.5%+93.4%-37.0%+87.9%-130.2%-276.5%-
PBT growth-70.6%+9998.0%-17.2%+87.3%-78.4%-3281.3%-
Net income growth-88.7%+146.9%+11.5%+88.4%-233.4%-1795.5%-
Revenue CAGR (3Y)-34.1%-100.0%-83.3%-56.0%-31.5%-21.3%+18.1%
EBITDA CAGR (3Y)-71.5%-77.8%-27.5%----13.6%
Profitability & leverage
Net income margin+20.0%--3322.8%-53.1%-119.4%-58.2%-0.5%
Return on capital employed+0.7%+0.8%0.0%0.0%0.0%-9.2%+1.4%
Return on net worth+0.6%+11.1%0.0%0.0%0.0%-17.2%-0.7%
Debt / equity0.003.190.840.430.440.400.33
Long-term debt / equity0.000.570.210.140.110.110.07
Interest cover-18.23-26.06-1.99-7.47-3.83-9.022,094.92
Efficiency & per share
Fixed asset turnover1,806.330.000.041.090.520.451.37
Inventory turnover0.000.004.56264.431,039.98384.13211.05
Debtors turnover492.640.000.193.392.541.363.61
EPS (₹)0.732.56(8.18)(6.86)(53.50)(30.91)(0.85)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)2.101.40(0.61)7.4312.3876.92107.74
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11.970.000.00(0.04)0.000.000.000.00
Revenue growth (YoY)-----100.0%---
Other income1.335.181.460.010.0110.872.91(0.35)
Total expenses12.330.790.350.282.025.881.7427.10
EBITDA(0.36)(0.79)(0.35)(0.32)(2.02)(5.88)(1.74)(27.10)
EBITDA margin-3.0%--+800.0%----
Depreciation0.000.000.000.000.000.010.010.01
Interest0.000.000.000.150.150.200.220.16
Profit before tax0.974.391.11(0.46)(2.16)4.780.94(27.62)
Tax0.000.000.000.160.000.000.00(0.06)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue0.000.905.4256.2318.0010.722.47
Revenue growth-100.0%-83.4%-90.4%+212.4%+67.9%+334.0%-
Other income6.6312.980.879.0717.2715.3226.08
Total expenses3.4482.8220858.8150917.5919.37
Employee cost0.421.062.012.784.474.126.32
EBITDA(3.44)(81.92)(203)(2.58)(491)(6.87)(16.90)
EBITDA margin--9102.2%-3739.1%-4.6%-2725.3%-64.1%-684.2%
Depreciation0.010.040.721.111.231.571.74
Interest0.290.750.740.680.300.360.49
Profit before tax2.89(69.73)(203)4.70(475)6.526.95
Tax0.160.004.010.412.37(1.28)(0.79)
Net profit2.72(69.68)(146)8.66(472)(6.02)7.74
Net profit margin--7742.2%-2702.8%+15.4%-2622.6%-56.2%+313.4%
EPS (₹)0.18(4.71)(14.01)0.29(32.26)0.530.52
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital14.7914.7914.7914.7914.7914.7914.79
Reserves & surplus13.6910.9880.62288284760751
Shareholders' funds (net worth)28.4825.7795.41303298775766
Secured loans0.000.000.000.000.000.000.00
Unsecured loans0.000.000.001.822.390.003.85
Total debt0.000.000.001.822.390.003.85
Total liabilities28.4925.7795.70305302776773
Assets
Gross block0.030.030.1710.0210.029.999.92
Net block0.000.010.112.123.234.435.97
Capital work in progress0.000.000.000.000.000.000.00
Investments0.250.00102243155517517
Inventories0.000.000.000.000.000.000.03
Sundry debtors0.000.000.000.004.302.377.00
Cash & bank balances0.263.220.606.532.7811.501.04
Loans & advances20.7819.246.2152.6297.62238227
Total current assets21.0422.466.8159.15105252235
Total current liabilities1.565.9023.4813.9110.0010.313.71
Net working capital19.4816.56(16.67)45.2494.70242232
Total assets28.4925.7795.70305302776773
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash3.160.506.222.5411.260.742.12
Net cash from operating activities(0.62)(19.51)(4.48)26.8932.58(2.66)(14.91)
Net cash from investing activities(1.99)22.21(1.02)(22.37)(40.19)13.4221.79
Net cash from financing activities(0.29)(0.04)(0.23)(0.84)(1.11)(0.25)(8.26)
Net change in cash(2.91)2.66(5.73)3.69(8.72)10.51(1.38)
Closing cash0.263.220.606.532.7811.501.04
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-100.0%-83.4%-90.4%+212.4%+67.9%+334.0%-
EBITDA growth+95.8%+59.6%-7755.0%+99.5%-7040.5%+59.4%-
PBT growth+9998.0%+65.7%-+9998.0%--6.2%-64.4%
Net income growth+103.9%+52.4%-1791.6%+101.8%-7741.5%-177.8%-
Revenue CAGR (3Y)-100.0%-63.2%-20.3%+183.4%-6.4%+63.8%-49.2%
EBITDA CAGR (3Y)+10.1%-44.9%+209.0%-46.6%+228.3%-24.9%+62.8%
Profitability & leverage
Net income margin--7747.8%-3824.0%+7.6%-2651.0%+72.8%+313.4%
Return on capital employed+0.9%0.0%0.0%+2.2%0.0%-0.9%+1.0%
Return on net worth+0.8%0.0%0.0%+1.8%0.0%-0.8%+1.0%
Debt / equity0.000.000.000.010.000.000.00
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-8.41-0.92-0.36-18.43-0.06-4.27-2.63
Efficiency & per share
Fixed asset turnover0.009.001.065.611.801.080.32
Inventory turnover0.000.000.000.000.00714.6782.33
Debtors turnover0.000.000.0026.155.402.290.37
EPS (₹)0.18(4.71)(14.01)0.29(32.26)0.530.52
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)1.931.746.4520.4720.1752.3951.77

Investments & Acquisitions by Take Solutions

Take Solutions has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include WCI Consulting.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
WCI Consulting
Technology management consulting services are provided to clients.
wcigroup.comPortsmouth, United Kingdom1986Jan 2011••••
Premium access

Complete acquisition details for Take Solutions

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Take Solutions

4 dated milestones of Take Solutions across 18 years, from founding to its latest funding, stage changes and deals.

  1. Founded Take Solutions is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires WCI Consulting.
  4. Funding First funding round of $40.0M.

Web traffic of Take Solutions

The website of Take Solutions (takesolutions.com) receives about 17.8K visits a month.

  • Monthly visits
    17.8K

    ▲ 76.7% vs previous month

Similar websites

Websites whose visitors overlap most with Take Solutions. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
CMGI
cmgi.com
100%
View details
MarketsMojo
marketsmojo.com
96%
834.5K#72,195View details
TAKE Supply Chain
takesupplychain.com
41%
View details
Cognizant
cognizant.com
40%
2.6M#21,051View details
VCCircle
vccircle.com
38%
274.4K#189,240View details
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 6 similar websites and full traffic analytics for Take Solutions

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Take Solutions (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Anthem Biosciences
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Laurus Labs
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
Entero Healthcare
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Take Solutions

Take Solutions reports consolidated net profit of Rs 1.06 crore in the June 2026 quarter | Capital Market News - Business Standard
Business Standard • 3 months ago
Take Solutions launches innovation fund with Rs 5 crore corpus
Moneycontrol • 7 months ago
Take Solutions Launches Ai-Driven Digital Health Platform Take.Health
Reuters • 7 months ago
250% return in one year! Multibagger small-cap stock hits upper circuit despite stock market crash | Stock Market News
mint • 8 months ago
Take Solutions To Build Unified AI Platform For Healthcare
Reuters • 8 months ago
TAKE Solutions to set up AI-enabled healthcare initiative in India - The Economic Times
Economic Times • 9 months ago
Take Solutions Ltd To Set Up 'One Minute Clinic' In India
Reuters • 9 months ago
TAKE Solutions to set up AI-enabled healthcare initiative in India
Moneycontrol • 9 months ago
Take Solutions Says Vedamirtham Venkatesan Resigns As CFO
Reuters • 10 months ago
Take Solutions reports consolidated net loss of Rs 0.91 crore in the June 2025 quarter | Capital Market News - Business Standard
Business Standard • 1 year ago
Premium access

Complete news archive for Take Solutions

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Take Solutions

Take Solutions was founded in 2000 and raised its 1st funding round 18 years after it was founded.

Take Solutions is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

Ram Yeleswarapu is the CEO of Take Solutions, as recorded in our data.

Take Solutions has 376 employees.

The primary company behind Take Solutions, Take Solutions Limited, reported revenue of ₹67.47 Cr for FY 2026, up 9997% year on year.

Take Solutions was founded in 2000 and is based in Chennai, India. Operations are centered on the life sciences sector, where clinical data management and regulatory solutions are delivered. In supply chain management, logistics optimization and inventory systems are offered to various industries. The company serves clients across multiple geographies, with leadership provided by CEO and President Ram Yeleswarapu.

Take Solutions offers Digital Healthcare Services and Supply Chain Management.

Yes, Take Solutions is publicly traded on NSE under the ticker symbol TAKE.

Take Solutions has made 1 acquisition, including WCI Consulting.

Take Solutions operates through Take Solutions Limited.

The legal entities of Take Solutions currently have 7 directors, including Vedamirtham Venkatesan, Parmeshvar Namdev Dhangare, Pushpa Joshi and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available